PREDICTING INDIVIDUAL PHENYTOIN DOSAGE

被引：133

作者：

VOZEH, S

MUIR, KT

SHEINER, LB

FOLLATH, F

机构：

[1] UNIV CALIF SAN FRANCISCO,DEPT LAB MED,SAN FRANCISCO,CA 94143

[2] KANTONSSPITAL,DEPT INTERNAL MED,DIV CLIN PHARMACOL,CH-4004 BASEL,SWITZERLAND

[3] UNIV CALIF SAN FRANCISCO,DEPT MED,DIV CLIN PHARMACOL,SAN FRANCISCO,CA 94143

来源：

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1981年 / 9卷 / 02期

关键词：

D O I：

10.1007/BF01068078

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：131 / 146

页数：16

共 19 条

[1] BEAL S, 1979, NONMEM USERS GUIDE 1
[2] GLAZKO AJ, 1969, CLIN PHARMACOL THER, V10, P498
[3] MICRODETERMINATION OF PLASMA DIPHENYLHYDANTOIN BY GAS-LIQUID-CHROMATOGRAPHY
GORDOS, J
SCHAUBLIN, J
SPRING, P
[J]. JOURNAL OF CHROMATOGRAPHY, 1977, 143 (02): : 171 - 181
[4] MANAGEMENT OF EPILEPSY WITH DIPHENYLHYDANTOIN SODIUM - DOSAGE REGULATION FOR PROBLEM PATIENTS
KUTT, H
MCDOWELL, F
[J]. JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1968, 203 (11): : 969 - &
[5] KUTT H, 1974, CLIN PHARMACOL THER, V16, P243
[6] LUDDEN TM, 1977, CLIN PHARMACOL THER, V21, P287
[7] ANTICONVULSANT EFFECT OF DIPHENYLHYDANTOIN RELATIVE TO PLASMA-LEVELS - PROSPECTIVE 3-YEAR STUDY IN AMBULANT PATIENTS WITH GENERALIZED EPILEPTIC SEIZURES
LUND, L
[J]. ARCHIVES OF NEUROLOGY, 1974, 31 (05) : 289 - 294
[8] LUND L, 1975, LANCET, V2, P1305
[9] CLINICAL PHARMACOKINETICS OF PHENYTOIN
MARTIN, E
TOZER, TN
SHEINER, LB
RIEGELMAN, S
[J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1977, 5 (06): : 579 - 596
[10] MULLEN PW, 1978, CLIN PHARMACOL THER, V23, P228